Skip to Content
Merck
  • Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.

Nature immunology (2014-04-01)
Jan Mauer, Bhagirath Chaurasia, Julia Goldau, Merly C Vogt, Johan Ruud, Khoa D Nguyen, Sebastian Theurich, A Christine Hausen, Joel Schmitz, Hella S Brönneke, Emma Estevez, Tamara L Allen, Andrea Mesaros, Linda Partridge, Mark A Febbraio, Ajay Chawla, F Thomas Wunderlich, Jens C Brüning
ABSTRACT

Obesity and resistance to insulin are closely associated with the development of low-grade inflammation. Interleukin 6 (IL-6) is linked to obesity-associated inflammation; however, its role in this context remains controversial. Here we found that mice with an inactivated gene encoding the IL-6Rα chain of the receptor for IL-6 in myeloid cells (Il6ra(Δmyel) mice) developed exaggerated deterioration of glucose homeostasis during diet-induced obesity, due to enhanced resistance to insulin. Tissues targeted by insulin showed increased inflammation and a shift in macrophage polarization. IL-6 induced expression of the receptor for IL-4 and augmented the response to IL-4 in macrophages in a cell-autonomous manner. Il6ra(Δmyel) mice were resistant to IL-4-mediated alternative polarization of macrophages and exhibited enhanced susceptibility to lipopolysaccharide (LPS)-induced endotoxemia. Our results identify signaling via IL-6 as an important determinant of the alternative activation of macrophages and assign an unexpected homeostatic role to IL-6 in limiting inflammation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O55:B5, Ready Made solution, 1 mg/mL
Sigma-Aldrich
Anti-Calnexin, C-Terminal (575-593) Rabbit pAb, liquid, Calbiochem®